| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.306 | 26.164 | 47.731 | 79.943 | 80.822 | 117.394 | 156.116 |
| Total Income - EUR | - | - | - | 2.306 | 26.164 | 47.731 | 79.943 | 80.822 | 117.394 | 156.116 |
| Total Expenses - EUR | - | - | - | 1.406 | 15.134 | 13.094 | 8.909 | 4.180 | 11.238 | 11.699 |
| Gross Profit/Loss - EUR | - | - | - | 900 | 11.030 | 34.637 | 71.033 | 76.643 | 106.156 | 144.417 |
| Net Profit/Loss - EUR | - | - | - | 831 | 10.245 | 33.268 | 68.923 | 74.911 | 105.006 | 139.827 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dianagynmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 806 | 1.953 | 1.058 | 3.849 | 1.956 | 491 | 106 |
| Current Assets | - | - | - | 139 | 9.878 | 48.585 | 109.512 | 143.049 | 106.414 | 141.900 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 1.214 | 20.151 | 20.715 | 24.696 | 54.292 | 102.507 |
| Cash | - | - | - | 139 | 8.665 | 28.434 | 88.796 | 118.354 | 52.122 | 39.393 |
| Shareholders Funds | - | - | - | 874 | 11.102 | 44.160 | 112.103 | 144.096 | 105.054 | 139.875 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 71 | 730 | 5.484 | 1.258 | 909 | 1.850 | 2.131 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dianagynmed S.r.l.